Format

Send to:

Choose Destination
See comment in PubMed Commons below
Int J Ophthalmol. 2013 Jun 18;6(3):397-401. doi: 10.3980/j.issn.2222-3959.2013.03.26. Print 2013.

Retinoblastoma: concerning its initiation and treatment.

Author information

  • 1Department of Ophthalmology, West China Hospital, Sichuan University, 37# Guo Xue Xiang, Chengdu 610041, Sichuan Province, China.

Abstract

Retinoblastoma (RB) is the most common intraocular cancer of infancy and childhood. This cancer is initiated by mutation on RB1, the tumor suppressor gene that is responsible for the regulation of both cell cycle and gnome stability in retinal cells. Patients with a constitutional mutation on RB1 can be inherited. RB occurs approximately 1 in every 15 000-20 000 live births. The worldwide mortality for this cancer is about 5%-11%. However, this rate rises to about 40%-70% in developing countries due to a delay in diagnosis. A wide variety of options are available for the treatment, but often a combination of therapies is adopted to optimize individualized care.

KEYWORDS:

epidemiology; leukocoria; medical management; retinoblastoma; retinoblastomal gene

PMID:
23826540
[PubMed]
PMCID:
PMC3693027
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for PubMed Central
    Loading ...
    Write to the Help Desk